The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.
about
Adjuvant radiotherapy for stage I endometrial cancerAdjuvant radiotherapy for stage I endometrial cancerAdjuvant radiotherapy for stage I endometrial cancerAdjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer.Late GI and bladder toxicities after radiation for uterine cancer.The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centreLate symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.The role of radiotherapy in endometrial cancer: current evidence and trendsEndometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?Is adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma?Contemporary quality of life issues affecting gynecologic cancer survivors.Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.An overview of uterine cancer and its management.The effect of postoperative beam, implant, and combination radiation therapy on GI and bladder toxicities in female Medicare beneficiaries with stage I uterine cancer.Intensity-Modulated Radiation Therapy Versus 3D Conformal Radiotherapy for Postoperative Gynecologic Cancer: Are They Covering the Same Planning Target Volume?Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis.The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.Patterns of care study for brachytherapy: results of the questionnaire for the years 2002 and 2007 in The Netherlands.Endometrial carcinoma: the current role of adjuvant radiation.Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer.Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy.Non-closure of peritoneum after abdominal hysterectomy for uterine carcinoma does not increase late intestinal radiation morbidityRecurrence and survival in surgically treated endometrioid endometrial cancer.Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma.Pelvic-Floor Properties in Women Reporting Urinary Incontinence After Surgery and Radiotherapy for Endometrial Cancer.Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study
P2860
Q24200253-85C9E465-1E62-4724-82DC-51461FEA70F3Q24201209-BABE115F-49F5-4262-B4FB-434F1198F189Q24245495-B0D5D945-9A70-44D9-80E2-7478B4CA50D0Q34355149-B0D40946-961A-4E2D-B163-CC7A6BDD08D5Q34516623-1704E625-C777-463B-ACCB-3EE4AFE96F62Q34719540-ACE79835-7006-4129-BF67-DAAF3A3D384FQ35208192-AD046377-EA30-4531-BE13-A3DCE69B2D6CQ35539990-4238FF8B-FA29-4274-9E3E-9F8DEFEF4D54Q35617503-8E43CFF6-1269-4939-9D0B-D840B9BB7EFCQ36029041-654861CD-1138-4C9B-8F68-010CFDF7A22DQ36067725-203C5EA5-69EE-460C-8C01-65F3AC358697Q36296947-8A8CCAA4-8180-466B-8D99-BB4AB0451CA2Q36352068-268A6B24-6D5E-4BFA-A6A2-7D283D725697Q36372740-B392FC56-F249-4003-AD02-59CD2EB5CD15Q36631978-63C99071-0444-4B0D-B10F-B81EF7779845Q36931011-3EE06AD8-A6BB-4CBB-9A7C-DDBE4FA0A4C5Q37214617-2F93AE38-E834-4E21-8DBB-A73BA5E6EE71Q37408104-547E6389-515D-4F99-AECB-155D2C48B38AQ37410937-8868E915-C3B2-44BA-8387-1FB78E0F66A6Q37520930-24E236C5-57E4-4BC4-BE23-BD5CA7A0F731Q38042049-62F4B4E2-0130-408D-A742-7800B8215227Q38853338-AA84149C-E4B9-4C78-BA7C-7DEE99DD3D1FQ39412377-4D36AD55-0182-4055-95E9-C3E24107704CQ41039861-F14E054E-E4E7-4991-9AD6-BB054718CE73Q41966422-2B5F6E38-C979-474D-9A73-AEF8E13B2722Q43986593-86DD6D17-E149-4793-93AC-973D5506321DQ44850838-B6E9D688-145F-405A-8B16-2F91046F910DQ48696044-40E541FB-D8B5-4F44-8DD6-68C8D67DB7D6Q49387212-F4111F1E-84D6-4EFE-9BFF-594BCC26F7D8Q52973484-E4BD738F-7318-43A4-A4C3-D555C05DCF25Q57903482-4388F707-DAA5-42D3-B023-151E117091DE
P2860
The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The morbidity of treatment for ...... sults from a randomized trial.
@ast
The morbidity of treatment for ...... sults from a randomized trial.
@en
type
label
The morbidity of treatment for ...... sults from a randomized trial.
@ast
The morbidity of treatment for ...... sults from a randomized trial.
@en
prefLabel
The morbidity of treatment for ...... sults from a randomized trial.
@ast
The morbidity of treatment for ...... sults from a randomized trial.
@en
P2093
P1476
The morbidity of treatment for ...... sults from a randomized trial.
@en
P2093
A C van den Bergh
C C Wárlám-Rodenhuis
C L Creutzberg
E van der Steen-Banasik
J J Jobsen
K A De Winter
L C Lutgens
M L Lybeert
M van Lent
P304
P356
10.1016/S0360-3016(01)01765-5
P407
P577
2001-12-01T00:00:00Z